FT819 in Subjects With B-cell Malignancies
Fate Therapeutics
Fate Therapeutics
Allogene Therapeutics
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Case Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Dana-Farber Cancer Institute
University Health Network, Toronto
National Institutes of Health Clinical Center (CC)
Stanford University
Caribou Biosciences, Inc.
Cedars-Sinai Medical Center
Fate Therapeutics
Fate Therapeutics
Dartmouth-Hitchcock Medical Center
Bristol-Myers Squibb
Fate Therapeutics
The Affiliated People's Hospital of Ningbo University
Loyola University
University of Rochester
Icahn School of Medicine at Mount Sinai
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Pittsburgh
Massachusetts General Hospital
Massachusetts General Hospital
M.D. Anderson Cancer Center
RenJi Hospital
University of Chicago
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center